Selma Schimmel sits with Cara Tenenbaum, VP for Policy and External Affairs at the Ovarian Cancer National Alliance. The Group Room at the 2011 American Association For Cancer Research Annual Meeting was made possible, in part, by:  

Karen Carlson sits with Selma Schimmel to discuss The Foundation for Women’s Cancer (formerly the Gynecologic Cancer Foundation) to talk about the foundation’s many programs including the Race to End Women’s Cancer being held in Washington D.C. the weekend of November 5-6, 2011. Also meet the band NED (No Evidence of Disease). The Group Room [...]

Thomas Herzog, MD, Director of Gynecologic Oncology and Professor of Clinical Gynecology and Obstetrics at Columbia University Medical Center. Dr. Herzog gives a ovarian cancer therapy update at ASCO 2011. The Group Room at the 2011 American Association For Cancer Research Annual Meeting was made possible, in part, by:     VIDEO TRANSCRIPT Selma R. [...]

Thomas Herzog, MD, Director of Gynecologic Oncology and Professor of Clinical Gynecology and Obstetrics at Columbia University Medical Center. Dr. Herzog discusses his involvement with The Foundation for Women’s Cancer at ASCO 2011. The Group Room at the 2011 American Association For Cancer Research Annual Meeting was made possible, in part, by:     VIDEO [...]

Beth Y. Karlan, MD gives an overview of what’s new in ovarian cancer screening at ASCO 2011. Beth Young Karlan, MD is Director of the Women’s Cancer Research Institute, the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and the Gilda Radner Cancer Detection Program. Dr. Karlan is also a professor of [...]

Beth Y. Karlan, MD gives an overview of ovarian cancer and PARP inhibitors at ASCO 2011. Beth Young Karlan, MD is Director of the Women’s Cancer Research Institute, the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and the Gilda Radner Cancer Detection Program. Dr. Karlan is also a professor of obstetrics [...]

Stephanie Huang, PhD, assistant professor of medicine (University of Chicago Comprehensive Cancer Center), will discuss how her research is advancing personalized medicine through the validation of pharmacogenomic markers for chemotherapy. To find out about how you can participate in Dr. Huang’s tissue collection for her exciting research, please contact Dr. Huang at rhuang {at} medicine [...]

Q. I had a complete hysterectomy for stage 3 ovarian cancer followed by 6 inpatient chemotherapy treatments. What is the difference between remission and cancer free? Can the cancer recur elsewhere? What do I have to be aware of? I see my oncologist every 4 months and get a CA125 test. A. I prefer the [...]